(VIANEWS) – RYANAIR HOLD. PLC (RYA.IR), REACH SUBSEA (REACH.OL), SMARTCRAFT (SMCRT.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. RYANAIR HOLD. PLC (RYA.IR)
38.7% sales growth and 28.95% return on equity
Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, and internationally. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services, as well as in-flight sale of beverages, food, duty-free, and merchandise; and markets car hire, travel insurance, and accommodation services through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. Ryanair Holdings plc was incorporated in 1996 and is headquartered in Swords, Ireland.
Earnings Per Share
As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €1.15.
PE Ratio
RYANAIR HOLD. PLC has a trailing twelve months price to earnings ratio of 14.47. Meaning, the purchaser of the share is investing €14.47 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.95%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 150% and a drop 144.4% for the next.
More news about RYANAIR HOLD. PLC.
2. REACH SUBSEA (REACH.OL)
19.4% sales growth and 24.57% return on equity
Reach Subsea ASA provides subsea services in Norway and internationally. It operates in two segments, Oil & Gas and Renewable/Other. The company offers inspection, maintenance, and repair services, such as structural inspections, WROV operation, SCM changeout, scale squeeze operations, water injection, ready for operation, subsea equipment maintenance, repair, commissioning, and boulder clearance; and construction support services, including seabed intervention, boulder clearance, touchdown monitoring, and pre-lay and post- lay survey, as well as vessel, remotely operated vehicles, personnel, survey, and on demand engineering. It also provides asset integrity/pipeline inspection, and engineering and project management services; reach remote services comprising survey, inspection, and IMR and seabed intervention; seabed survey services consisting of site surveys and geohazard investigation, pipeline inspection, seabed mapping, UXO, general, and route surveys; offshore cable; marine construction; and rig and mooring services. In addition, the company offers geophysical monitoring services, which include 4D gravity, seafloor subsidence monitoring, depth watch for seismic nodes, injection integrity monitoring, well drilling, and real time seismic monitoring services; and environmental monitoring services that comprise earthquake monitoring and prediction, C02 storage, and geothermal energy exploitation. It serves oil and gas, renewables, and utilities sectors. The company was formerly known as Transit Invest ASA and changed its name to Reach Subsea ASA in December 2012. Reach Subsea ASA was incorporated in 1909 and is headquartered in Haugesund, Norway.
Earnings Per Share
As for profitability, REACH SUBSEA has a trailing twelve months EPS of kr0.67.
PE Ratio
REACH SUBSEA has a trailing twelve months price to earnings ratio of 6.76. Meaning, the purchaser of the share is investing kr6.76 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.57%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
REACH SUBSEA’s EBITDA is 1.54.
Yearly Top and Bottom Value
REACH SUBSEA’s stock is valued at kr4.53 at 12:20 EST, way under its 52-week high of kr5.22 and way higher than its 52-week low of kr3.50.
Volume
Today’s last reported volume for REACH SUBSEA is 199523 which is 55.65% below its average volume of 449903.
More news about REACH SUBSEA.
3. SMARTCRAFT (SMCRT.OL)
18.1% sales growth and 11.51% return on equity
SmartCraft ASA provides software solutions to the construction industry in Norway, Sweden, and Finland. The company offers Cordel; Bygglet, a SaaS born in the cloud solution; EL-VIS, a solution for electricians; and Congrid, a cloud-based tool for project management in construction companies. It also provides HomeRun, a digital tool for construction, project communication, document, and procurement management; Kvalitetskontroll, a cloud-based project management solution and quality assurance platform for construction companies; El-verdi, a digital sales tool for electricians; and ELinn, a cloud based solution for electricians to handle project management services. The company was founded in 1987 and is headquartered in Hønefoss, Norway.
Earnings Per Share
As for profitability, SMARTCRAFT has a trailing twelve months EPS of kr0.53.
PE Ratio
SMARTCRAFT has a trailing twelve months price to earnings ratio of 37.45. Meaning, the purchaser of the share is investing kr37.45 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.51%.
More news about SMARTCRAFT.
4. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 32.46. Meaning, the purchaser of the share is investing kr32.46 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
More news about NAVAMEDIC.
5. NORBIT (NORBT.OL)
9.7% sales growth and 27.5% return on equity
Norbit ASA provides technology products and solutions. It operates through Oceans, Connectivity, and Product Innovation and Realization segments. The company offers multibeam sonar systems, including integrated bathymetric systems, bathymetry systems, advanced monitoring systems for dredging, construction and renewables, forward looking wide area imaging, advanced imaging systems for obstacle avoidance/MCM, and above water laser products under the NORBIT WINGHEAD, NORBIT WBMS, NORBIT NORdredge, and NORBIT FLS names; customized cable assemblies, electromechanical box builds, and operational solutions; SeaCOP, a sensor integration platform and user interface common operational picture for emergency response; SECurus provides thermal and daylight stabilized camera solutions; SeaView, which offers thermal and daylight, pan, tilt, and zoom for environmental monitoring, and security and general surveillance; and SeaDarQ, a radar processing solution. It also provides sensing solutions for detecting threats at sea plus waterside security above and below the surface; FCL600, an underwater light solution for aquaculture industry; iData, which offers vehicle monitoring, telematics services, and fleet management for asset and vehicle management; and dedicated short-range communication technology for traffic system and vehicle application. In addition, the company offers research and development services, and contract manufacturing to industrial customers; and sells products based on proprietary technology, including special instrumentation n based on radar, radio frequency, and embedded signal processing technology. The company was founded in 1995 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, NORBIT has a trailing twelve months EPS of kr2.9.
PE Ratio
NORBIT has a trailing twelve months price to earnings ratio of 20.9. Meaning, the purchaser of the share is investing kr20.9 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.5%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 5, 2023, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 1.14%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 145% and 1.5%, respectively.
Yearly Top and Bottom Value
NORBIT’s stock is valued at kr60.60 at 12:20 EST, below its 52-week high of kr67.00 and way above its 52-week low of kr22.90.
Revenue Growth
Year-on-year quarterly revenue growth grew by 32.4%, now sitting on 1.41B for the twelve trailing months.
More news about NORBIT.
6. MEDISTIM (MEDI.OL)
5.8% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.41.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 34.17. Meaning, the purchaser of the share is investing kr34.17 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MEDISTIM’s EBITDA is 7.97.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 11.9% and a drop 6.2% for the next.
Yearly Top and Bottom Value
MEDISTIM’s stock is valued at kr219.00 at 12:20 EST, way under its 52-week high of kr312.50 and way higher than its 52-week low of kr184.80.
Moving Average
MEDISTIM’s value is way below its 50-day moving average of kr257.26 and way below its 200-day moving average of kr251.43.
More news about MEDISTIM.
